Analysts upwardly revised their ratings and price targets on SRPT, STX, and SU
Analysts are weighing in on drugmaker Sarepta Therapeutics Inc (NASDAQ:SRPT), data storage stock Seagate Technology PLC (NASDAQ:STX), and energy firm Suncor Energy Inc. (USA) (NYSE:SU). Here's a quick roundup of today's bullish brokerage notes on shares of SRPT, STX, and SU.
Sarepta Stock Soars on SunTrust Note
SRPT has surged 4.6% to trade at $30.13, following an upgrade to "buy" from "hold" at SunTrust Robinson. The brokerage firm explained, "encouraging long-term data on cardiac and pulmonary function can support payer coverage on co's only drug, Exondys 51." That said, Sarepta Therapeutics Inc shares have been more than cut in half since hitting a 13-year high near $64 in late September. Still, options traders are extremely call-skewed toward the stock. SRPT sports a Schaeffer's put/call open interest ratio (SOIR) of 0.36, which ranks lower than all readings taken in the past year.
Seagate Shares Stay Hot on Positive Price-Target Revision
STX stock has tacked on 2.2% at $46.96, buoyed by RBC's price-target hike to $50 from $45 -- in annual-high territory. Technically speaking, the shares have caught fire since bottoming at $18.42 last May, up over 155%. This bullish price action could pave the way for upgrades. Despite Seagate Technology PLC's long-term gains, 15 of 21 analysts still maintain "hold" or worse opinions.
Suncor Now a Goldman "Conviction Buy"
Goldman Sachs added SU stock to its "Americas conviction buy" list. The move has lifted the shares 2.2% to $31.29 -- though they remain slightly lower on a year-to-date basis. Generally speaking, the brokerage bunch is bullishly arrayed toward the recent underperformer. Ten analysts rate Suncor Energy Inc. a "buy" or better, compared to three "holds" and not a single "sell."